Medical Properties Trust: 7.4% Dividend After 70% Cut — Buy or Avoid?

Medical Properties Trust — NYSE: MPW, also known as MPT — is one of the most painful positions for dividend investors over the past several years. From a peak above $20 to under $4. Dividend cut three times. Two major tenants in crisis. And yet one of the world’s largest hospital landlords still holds a dividend yield of 7.4%.

In this analysis I go through the full story: where the crash came from, what the Q4 2025 turnaround is worth in practical terms, and what Q1 2026 earnings must show for the investment thesis to hold.

My position, transparent: 229 shares at an average of €5.45 — current price €4.41. Book loss €237 minus €119 in received dividends = net loss €118 at time of recording. No sugarcoating.

Medical Properties Trust Analysis 2026: 7.4% Dividend After 70% Cut

1. What Is Medical Properties Trust and How Does It Work?

Medical Properties Trust is not a conventional real estate REIT with office buildings or logistics parks. It is a specialized hospital landlord operating through sale-leaseback transactions: MPW buys hospital buildings from operators and immediately leases them back long-term (typically 15-20 years). The operator gets fresh capital for investment or debt reduction; MPW gets a long-term tenant and predictable rent cash flows. Understanding REIT-specific metrics like FFO and AFFO is essential to evaluate whether MPW's turnaround creates real dividend capacity.

With over 400 hospitals in nine countries — USA, UK, Germany, Australia, Switzerland, Finland, Colombia, Portugal, Spain — MPW ranks among the largest hospital property owners in the world. The model sounds inherently defensive: healthcare is not cyclical, hospitals cannot simply relocate, and demographic trends create permanently high demand.

Upstream Hub: Best Upstream Oil & Gas Stocks 2026 — top producers ranked by dividend yield, FCF generation, and reserve life.

2. The Three Crash Bombs: How Medical Properties Trust Ended Up in Crisis

The stock decline of Medical Properties Trust is explained by three parallel shocks between 2023 and 2025:

3. Q4 2025: The Turnaround Is Real

The first significant positive signal came with Q4 2025 results: Medical Properties Trust posted a net profit of +$17 million — the first profitable quarter after a prolonged loss period. Most of the Steward write-downs are behind it, and the Prospect exposure is being replaced by the California deal.

In parallel, the dividend was confirmed at $0.09 per quarter. That is the stabilizing base: 7.4% yield paid while waiting for normalization. In the REIT cycle, this is an interesting starting position — provided one can carry the risk profile.

4. Key Metrics: Where Does Medical Properties Trust Stand in 2026?

• Share Price (April 2026): ~$4.85 (USD) / ~€4.41
• Dividend: $0.09/quarter = $0.36 annualized
• Dividend Yield: ~7.4%
• Portfolio: 400+ hospitals across 9 countries
• NFFO Q4 2025: Positive — first turnaround after loss quarters
• California Deal: $45M/year, 15-year term (through 2039)
• Market Cap: ~$2.9B — trading well below historical book value

5. My Position and Decision Framework

229 shares at €5.45 average. Book loss €237. Dividends received €119. Net position: −€118. This is my biggest open wound in the portfolio — but I am holding deliberately:

• Turnaround is real: Q4 2025 showed positive NFFO for the first time again.
• California deal: Secures $45M/year for 15 years — hard rent visibility through 2039.
• Dividend paid while waiting: 7.4% yield compensates for the holding period.
• Rate pivot option: REITs structurally benefit from falling rates. At a Fed pivot from 2027, MPW could respond disproportionately.

6. Q1 2026 Earnings Check: What Must Medical Properties Trust Deliver?

Q1 2026 results were published on April 30, 2026 before market open. My clear decision framework:

• MUST: Positive NFFO — negative NFFO is an immediate sell signal.
• MUST: Dividend confirmed at $0.09 for Q2 2026 — any further cut forces position reduction.
• SHOULD: California deal payments on track ($45M/year progressing as planned).
• BONUS: New tenant pipeline for remaining Steward properties — further occupancy recovery.
• WARNING: Guidance cut or new material tenant problems → immediate reassessment required.

The REIT series continues with REIT #02 STAG Industrial. In parallel, the Pharma series runs with Novo Nordisk as #01. Medical Properties Trust stays on my active watchlist with clearly defined trigger points in both directions.

7. Historical Context — REIT Recovery Cycles and What They Mean for MPW

REITs as an asset class have recovered from distress before. Understanding historical precedents helps calibrate what a recovery timeline for Medical Properties Trust might look like:

The 2008–2009 financial crisis saw major REIT operators slash dividends aggressively — some by 70–90% — only to see those same dividends restored and even surpassed within 5–7 years as properties stabilized and rates fell. The trigger in every case was the same: cash flow normalization, followed by credit market reopening, followed by multiple expansion as investors returned.

For MPW specifically, the normalization pathway depends on three sequential steps:

1. Tenant stabilization: No new material tenant defaults. The California deal demonstrates MPW can still attract 15-year hospital leases — that is the proof point.
2. NFFO coverage: Normalized FFO consistently covering the $0.09 dividend, with room to rebuild reserves. This is a 12–18 month story from Q4 2025.
3. Balance sheet normalization: Debt reduction through asset sales + maturities rolled at manageable spreads. This is a 2–3 year story.

If all three steps execute, the valuation case becomes compelling: MPW at current prices trades at a deep discount to Net Asset Value (NAV) — the intrinsic value of the hospital portfolio. The question is whether one believes the portfolio stabilizes and the balance sheet heals, or whether further deterioration requires additional write-downs.

8. REIT Valuation: P/FFO and Price-to-NAV

Traditional P/E ratios are not appropriate for REITs, which report large non-cash depreciation charges that distort earnings. The correct valuation metrics are:

• P/FFO (Price to Funds From Operations): FFO adds back depreciation to net income, reflecting the true cash generation of the portfolio. MPW's depressed P/FFO is among the lowest in the healthcare REIT sector.
• Price-to-NAV: Book value of properties minus liabilities, divided by shares outstanding. MPW trades at a significant discount to its estimated NAV, reflecting market skepticism about property valuations and tenant quality.

9. How Much Does the Rate Environment Matter?

REITs carry a structural sensitivity to interest rates that many investors underestimate:

• Cost of capital: REITs are leveraged real estate businesses. Higher rates increase the cost of refinancing debt. MPW has debt maturities in 2026–2028 that will need to be rolled at current or near-current rates — that is a genuine headwind on interest expense.
• Valuation multiple: When Treasury yields are high, investors demand a higher spread from REITs. This compresses P/FFO multiples across the entire sector, regardless of individual company quality. MPW faces both the company-specific risk discount AND the sector-wide rate discount.
• The forward look: If the Fed initiates a genuine easing cycle in 2027, both headwinds reverse simultaneously: lower refinancing costs AND re-rating of REIT multiples. That is the scenario where MPW — as one of the most discounted REITs in the sector — could see outsized percentage recovery.

10. Dividend Framework — Can $0.09 Be Sustained?

The central question for dividend investors: is $0.09 per quarter the floor, or is there still a cut risk?

Analyzing the coverage: MPW's Q4 2025 Normalized FFO suggests approximately $0.10–0.11 per share per quarter on a stabilized basis. That provides modest but real coverage of the $0.09 dividend. There is no room for error, but there is genuine coverage — unlike in 2023–2024 when the dividend exceeded available cash flow.

For investors who want high current income with recovery potential, the MPW setup has a specific profile: high risk, high yield, defined catalyst path, and clear exit triggers. That combination is not appropriate for conservative dividend investors but can make sense as a small recovery allocation for investors willing to accept the binary nature of the outcome.

Key Metric: Free Cash Flow (FCF) determines dividend safety — full guide with sector benchmarks for shipping, mining & energy.

Glossary: Dividend Safety explained — payout ratio, FCF coverage, net debt, and the 5 metrics that predict dividend cuts before they happen.

AuthorMarco Bozem

Independent hard-asset investor since 2022. Covers dividends from shipping, mining, energy & pipelines from a real private-investor portfolio — with disclosed positions on every analysis.

About Marco →YouTubeLinkedIn